Core Insights - Catheter Precision, Inc. has expanded its global sales footprint to 15 countries following a purchase order from the University Clinical Center Ljubljana in Slovenia [1][3]. Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing advanced products for the cardiac electrophysiology market [6]. - The company aims to improve the treatment of cardiac arrhythmias through innovative technology and collaboration with physicians [6]. Product Information - VIVO (View Into Ventricular Onset) is a non-invasive 3D imaging system that helps identify the origin of ventricular arrhythmias pre-procedure, streamlining workflow and reducing procedure time. It has received marketing clearance from the U.S. FDA and the CE Mark [5]. - LockeT is a suture retention device designed to assist in wound closure after percutaneous venous punctures. It is a Class 1 device registered with the FDA and has also received CE Mark approval [4]. Market Position and Growth - The recent purchase order signifies the company's successful navigation of international regulatory landscapes and the establishment of strong distribution partnerships [3]. - The CEO of Catheter Precision expressed optimism about the company's growth trajectory and the effectiveness of its products in addressing real-world challenges in electrophysiology lab workflows [3].